In this study, we found LOX-1 was up-regulated in malignant tumors compared with adjacent normal gastric tissues, suggesting that LOX-1 may not only involve in GC tumorigenesis, but potentially served as a robust linkage among ROS, metabolic disorders and GC development. Here, OLR1 is linked to metabolic disease.